SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IOTA

IOTA is gaining attention as the community highlights institutional utility partnerships and new technical integrations, alongside a strategic pivot toward global trade infrastructure. Market participants are debating its long-term potential as a foundational DLT technology, often grouping it with other ISO 20022-compliant projects while monitoring oversold technical signals.

iShares Trust - iShares 0-3 Month Treasury Bond ETF

iShares 0-3 Month Treasury Bond ETF

Investors are flocking to SGOV as a safe haven for capital preservation amid growing concerns over market instability, recession fears, and the volatility of long-term bond yields. The community is actively discussing the ETF as a strategic, liquid alternative to high-yield savings accounts, prioritizing monthly income and stability while waiting for clearer entry points in broader equity markets.

What is Chromia? Chromia is an open source public blockchain conceived of by Swedish company Chromaway AB. The Chroma token (CHR) was launched in May of 2019. The technology behind the Chromia blockchain is adapted from an earlier technology called ‘Postchain’, a solution provided by Chromaway AB for enterprise clients.&nbsp;  How does Chromia work? Chromia is a standalone Layer-1 blockchain and EVM compatible Layer-2 enhancement for Binance Smart Chain and Ethereum. It is designed to enhance existing dApps and allow for the creation of next-generation dApps by providing scalability, improved data handling, and customizable fee structures. The blockchain uses a unique architecture called relational blockchain, as well as a custom programming language called Rell.  Rell is designed to code and function very similarly to SQL, allowing developers to leverage the security and immutability of blockchain while storing and handling data with the efficiency of a relational database.&nbsp; Each dApp running on Chromia operates on its own sidechain which is rooted in the main blockchain. This allows each application to scale more efficiently and gives each application developer the freedom to choose from a variety of fee structures. For example, one application may require users to pay transaction fees in CHR (similar to how Ethereum or Bitcoin work), while another application could stake enough CHR to reserve computational power and allow their users to make unlimited transactions without paying any fees at all.&nbsp;  What applications have been built on Chromia? Chromia already has a wide variety of applications building upon their blockchain, using their chain as a decentralized storage layer, and using their Layer-2 enhancements. These applications range from DeFi options trading platform Hedget, to open world farming game My Neighbor Alice, to government land registry initiative LAC PropertyChain.&nbsp; One of the latest features in development is a new NFT standard called Chromia Originals, which will operate both as a native standard on Chromia’s chain as well as an enhancement layer for existing ERC-721 and BEP-721 tokens. Work on these Layer-2 enhancements are being developed in cooperation with My Neighbor Alice.  Who is behind Chromia? Chromia’s core team consists of industry veterans Or Perelman, Henrik Hjelte and Alex Mizrahi. All three have deep roots in the crypto space, going back to the early days of Bitcoin and Ethereum. For example, Alex published several early academic papers on Proof of Stake consensus and was also one of the key figures behind Colored Coins, one of the first projects to develop the idea of ‘tokens’ that would later be brought to prominence by Ethereum.  In summary, Chromia is a Layer-1 and Layer-2 blockchain solution under active development, with the goal of delivering enhanced features and data handling and storage capabilities to decentralized applications.

Chromia

Chromia is currently seeing significant community interest driven by the project's ongoing development in the metaverse and gaming sectors, with many users highlighting its potential as a low-market-cap 'sleeper' gem. Investors are actively discussing the platform's Layer-1 technology and its expanding ecosystem, frequently comparing its long-term growth prospects to other established gaming-focused blockchain projects.

iShares Ethereum Trust (The) - iShares Ethereum Trust ETF

iShares Ethereum Trust ETF

The iShares Ethereum Trust ETF (ETHA) is seeing heightened investor activity as market participants navigate recent institutional outflows and price volatility across the crypto complex. The community is actively debating the reliability of long-term holding strategies in crypto-linked assets while closely monitoring whale positioning and options activity for potential signs of stabilization.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust ETF is trending as investors monitor broader market volatility and institutional flows amid shifting geopolitical tensions and ongoing debates over Bitcoin's role as a digital hedge. The community is actively discussing the potential impact of macro-economic catalysts, including energy market pressures and regulatory clarity, which continue to drive intense interest and varied sentiment across crypto-linked assets.

DEGEN is a reward token for Farcaster users, born from meme culture. It features a unique tipping system that allows the community to reward high-quality content creators. DEGEN also powers the Degen Chain, one of the pioneering Layer 3s launched on Base. Known as the “Las Vegas of blockchains,” it provides a platform for building and using Degen apps, offering a space for fun, innovation, and community-driven experiences.

Degen

DEGEN is experiencing heightened community activity as holders react to strategic token buybacks, burns, and anticipation for upcoming platform updates. Investors are actively debating the token's long-term utility versus its status as a high-conviction meme play, while monitoring key technical resistance levels for a potential breakout.

First Trust Exchange-Traded Fund II - First Trust NASDAQ Cybersecurity ETF

First Trust Exchange-Traded Fund III - First Trust NASDAQ Cybersecurity ETF

The cybersecurity sector is seeing increased investor attention as ongoing geopolitical tensions and the threat of cyber warfare drive sustained demand for digital defense. Community sentiment remains largely bullish, with many focusing on cybersecurity ETFs like CIBR as a strategic way to gain diversified exposure to essential players in a rapidly expanding market.

Teledyne Technologies, Inc. engages in the provision of electronic and communication products for wireless and satellite systems. It operates through the following business segments: Instrumentation, Digital Imaging, Aerospace and Defense Electronics, and Engineered Systems. The Instrumentation segment provides monitoring and control instruments for marine, environmental, industrial, and other applications, and electronic test and measurement equipment. The Digital Imaging segment includes high-performance sensors, cameras, and systems within the visible, infrared, ultraviolet, and X-ray spectra. The Aerospace and Defense Electronics segment offers electronic components and subsystems, data acquisition and communications components and equipment, harsh environment interconnects, and general aviation batteries. The Engineered Systems segment consists of systems engineering, integration and advanced technology development, and complex manufacturing solutions. The company was founded in 1960 and is headquartered in Thousand Oaks, CA.

Teledyne Technologies Inc

Teledyne Technologies is seeing positive sentiment driven by new defense contracts, including a recent Army agreement for loitering munitions, while the community debates whether the stock's tendency to dip after strong earnings reports is a buying opportunity. Traders are closely watching its technical stability near support levels, with many viewing the company's solid fundamentals and government-backed project pipeline as a long-term play on defense modernization.

XYO is the original and one of the largest Decentralized Physical Infrastructure Networks (DePIN), boasting over 10 million nodes and consistently leading DePIN in both scale and revenue generation. Launching its Mainnet ahead of any other DePIN, XYO specializes in collecting and validating real-world data, bridging it seamlessly to Web3 and Web2 companies across AI, geolocation, and other critical data sectors. At the core of XYO are Proof of Location and Proof of Origin technologies, enabling accurate validation of real-world data for innovative use cases such as Real-World Asset (RWA) tracking, DePIN applications, real-world gaming, and treasure hunts. Recently, XYO expanded its ecosystem by launching the XYO Layer One blockchain, purpose-built to support the intensive data demands of DePIN, RWA, AI, and similar data-driven industries. XYO employs a unique dual-token model: XYO Token: An externally traded token supporting the DePIN ecosystem, rewards, staking, and governance, enhancing overall ecosystem value and scarcity.   XL1 Token: Internal to the XYO Layer One blockchain, facilitating transactions, gas fees, and other blockchain-specific use cases. The dual-token economics are strategically designed to increase scarcity and promote sustainable growth. The XYO token is available on major exchanges, including Coinbase. The XL1 token will launch publicly later in 2025. To accelerate network adoption and growth, XYO created the popular COIN app. Beyond the XYO Foundation, the team founded the U.S.-based, for-profit entity XY Labs Inc., notable as the first U.S. crypto company qualified by the SEC for a Regulation A offering, permitting share sales to both accredited and non-accredited investors. XY Labs further stands out as one of the pioneering U.S. companies to tokenize and publicly list its shares. These tokenized shares trade as $XYLB on the tZERO ATS, positioning XY Labs prominently in the growing wave of Real-World Asset (RWA) tokenization.

XYO Network

XYO Network is seeing heightened activity and community discourse as investors debate its potential in the DePin sector amid ongoing speculation regarding major tech partnerships and future utility. While some users are actively accumulating during price consolidation, others remain skeptical, frequently labeling recent volatility as recurring pump-and-dump behavior.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is currently trending as investors monitor ongoing institutional positioning and anticipation ahead of upcoming clinical data and the PDUFA date for its IgA nephropathy treatment, atacicept. The community is actively discussing the stock's potential as a buyout candidate and debating its competitive positioning within the dual-inhibition landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rhythm Pharmaceuticals Analysts Boost Their Forecasts Following Upbeat Q1 Results

Rhythm Pharmaceuticals (NASDAQ: RYTM) reported better-than-expected earnings, with strong demand for IMCIVREE and potential launches in Europe and Japan.read more...

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $137.00 at Royal Bank Of Canada

Royal Bank Of Canada increased their price objective on shares of Rhythm Pharmaceuticals from $136.00 to $137.00 and gave the company an "outperform" rating in a research report on Wednesday...

Wells Fargo & Company Boosts Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $144.00

Wells Fargo & Company boosted their price target on Rhythm Pharmaceuticals from $143.00 to $144.00 and gave the stock an "overweight" rating in a research note on Wednesday...

Why Rhythm Pharmaceuticals Stock Triumphed on Tuesday

Key PointsThe biotech was in the headlines recently after the FDA approved a new indication for its single commercialized drug...

Rhythm Pharmaceuticals Q1 Earnings Call Highlights

Rhythm Pharmaceuticals (NASDAQ:RYTM) reported first-quarter 2026 revenue growth as the company began its U.S. commercial launch of IMCIVREE for acquired hypothalamic obesity (HO) and highlighted new regulatory progress in Europe and Japan.

First-quarter results show continued IMCIVREE growth

Chair...

Rhythm Pharmaceuticals (NASDAQ:RYTM) Announces Earnings Results

Rhythm Pharmaceuticals (NASDAQ:RYTM - Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.83) earnings per share for the quarter, topping analysts' consensus...

Rhythm Pharmaceuticals (NASDAQ:RYTM) Shares Gap Up  After Earnings Beat

Rhythm Pharmaceuticals (NASDAQ:RYTM) Shares Gap Up on Better-Than-Expected Earnings...

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Tops Revenue Estimates

Rhythm Pharmaceuticals (RYTM) delivered earnings and revenue surprises of +3.04% and +5.43%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Vanguard Group Inc. Purchases 1,214,489 Shares of Rhythm Pharmaceuticals, Inc. $RYTM

Vanguard Group Inc. boosted its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 24.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,210,916 shares of the company's stock after buying an ad...

Rhythm Pharmaceuticals, Inc. $RYTM Shares Bought by Jennison Associates LLC

Jennison Associates LLC grew its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 123.2% in the 4th quarter, according to its most recent disclosure with the...

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.

RYTM
Rhythm Pharmaceuticals Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest RYTM News

RYTMRhythm Pharmaceuticals Inc.